New drug candidate that reprograms the immune system shows promise as a brain cancer treatment
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive and most common type of primary brain cancer in adults. In preclinical ...
13 hours ago
0
4









